Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HHH Howard Hughes	$70.52 0.0%	$69.06	$59.83 ▼ $87.77	$3.55B	1.21	378,333 shs	354,079 shs
TSHA Taysha Gene Therapies	$2.64	$2.54	$1.05 ▼ $3.31	$566.70M	0.97	2.95 million shs	4.15 million shs
WPC W.P. Carey	$63.50 +1.1%	$62.34	$52.91 ▼ $66.10	$13.90B	0.78	1.16 million shs	821,532 shs
ZG Zillow Group	$76.18 +1.2%	$68.19	$40.30 ▼ $86.58	$18.39B	2.09	556,850 shs	423,307 shs

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HHH Howard Hughes	0.00%	+1.71%	+1.94%	+7.22%	-1.45%
TSHA Taysha Gene Therapies	0.00%	+10.00%	+3.94%	+106.25%	+11.39%
WPC W.P. Carey	0.00%	-0.29%	-0.76%	+4.98%	+7.68%
ZG Zillow Group	0.00%	+6.98%	+9.02%	+22.02%	+54.04%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
HHH Howard Hughes	2.3861 of 5 stars	2.3	3.0	0.0	0.0	1.9	3.3	1.3
TSHA Taysha Gene Therapies	4.0508 of 5 stars	4.5	5.0	0.0	0.0	2.6	3.3	0.0
WPC W.P. Carey	4.5957 of 5 stars	4.1	4.0	1.7	2.8	3.4	1.7	0.0
ZG Zillow Group	4.3586 of 5 stars	2.2	5.0	0.0	3.4	3.4	1.7	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
HHH Howard Hughes	2.67	Moderate Buy	$80.33	13.92% Upside
TSHA Taysha Gene Therapies	3.00	Buy	$8.17	209.34% Upside
WPC W.P. Carey	2.10	Hold	$104.22	64.13% Upside
ZG Zillow Group	2.48	Hold	$82.45	8.23% Upside

Current Analyst Ratings Breakdown

Latest HHH, TSHA, ZG, and WPC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/11/2025	TSHA Taysha Gene Therapies	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$8.00
7/8/2025	ZG Zillow Group	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$60.00 ➝ $75.00
7/2/2025	WPC W.P. Carey	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	In-Line ➝ In-Line	$65.00 ➝ $66.00
7/1/2025	TSHA Taysha Gene Therapies	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$8.00
6/23/2025	HHH Howard Hughes	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Neutral	$82.00 ➝ $76.00
6/10/2025	TSHA Taysha Gene Therapies	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$8.00
6/9/2025	WPC W.P. Carey	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Neutral	$66.00
6/9/2025	WPC W.P. Carey	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
6/9/2025	WPC W.P. Carey	BNP Paribas Exane Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Underperform ➝ Neutral	$66.00
6/3/2025	TSHA Taysha Gene Therapies	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$9.00 ➝ $11.00
6/2/2025	TSHA Taysha Gene Therapies	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$6.00 ➝ $8.00

(Data available from 7/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
HHH Howard Hughes	$1.75B	2.03	$9.69 per share	7.28	$56.65 per share	1.24
TSHA Taysha Gene Therapies	$8.33M	68.03	N/A	N/A	$0.35 per share	7.54
WPC W.P. Carey	$1.60B	8.67	$4.58 per share	13.86	$38.54 per share	1.65
ZG Zillow Group	$2.24B	8.23	$0.73 per share	104.95	$19.99 per share	3.81

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
HHH Howard Hughes	$200.55M	$5.21	13.53	76.65	N/A	14.27%	10.21%	3.08%	N/A
TSHA Taysha Gene Therapies	-$89.30M	-$0.34	N/A	N/A	N/A	-1,201.08%	-104.93%	-50.09%	8/11/2025 (Estimated)
WPC W.P. Carey	$460.84M	$1.94	32.73	13.45	6.99	26.66%	5.02%	2.43%	7/29/2025 (Estimated)
ZG Zillow Group	-$112M	-$0.34	N/A	71.20	13.91	-3.51%	-1.62%	-1.25%	8/6/2025 (Estimated)

Latest HHH, TSHA, ZG, and WPC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/11/2025	Q2 2025	TSHA Taysha Gene Therapies	-$0.07	N/A	N/A	N/A	$1.61 million	N/A
8/6/2025	N/A	ZG Zillow Group	$0.44	N/A	N/A	N/A	$647.06 million	N/A
7/29/2025	Q2 2025	WPC W.P. Carey	$1.23	N/A	N/A	N/A	$420.99 million	N/A
5/15/2025	Q1 2025	TSHA Taysha Gene Therapies	-$0.08	-$0.08	N/A	-$0.08	$1.48 million	$2.30 million
5/7/2025	Q1 2025	HHH Howard Hughes	$0.13	$0.21	+$0.08	$0.21	$187.43 million	$199.33 million
5/7/2025	Q1 2025	ZG Zillow Group	$0.47	$0.41	-$0.06	$0.03	$587.88 million	$598.00 million
4/29/2025	Q1 2025	WPC W.P. Carey	$1.20	$1.17	-$0.03	$1.17	$412.99 million	$407.44 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
HHH Howard Hughes	N/A	N/A	N/A	N/A	N/A
TSHA Taysha Gene Therapies	N/A	N/A	N/A	N/A	N/A
WPC W.P. Carey	$3.60	5.67%	N/A	185.57%	2 Years
ZG Zillow Group	N/A	N/A	N/A	N/A	N/A

Latest HHH, TSHA, ZG, and WPC Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/12/2025	WPC W.P. Carey	quarterly	$0.90	5.69%	6/30/2025	6/30/2025	7/15/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
HHH Howard Hughes	1.84	1.41	1.41
TSHA Taysha Gene Therapies	0.77	5.35	5.35
WPC W.P. Carey	0.92	0.23	0.23
ZG Zillow Group	N/A	2.46	2.46

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
HHH Howard Hughes	93.83%
TSHA Taysha Gene Therapies	77.70%
WPC W.P. Carey	73.73%
ZG Zillow Group	20.32%

Insider Ownership

Company	Insider Ownership
HHH Howard Hughes	33.00%
TSHA Taysha Gene Therapies	3.78%
WPC W.P. Carey	0.93%
ZG Zillow Group	17.14%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
HHH Howard Hughes	608	50.39 million	33.76 million	Optionable
TSHA Taysha Gene Therapies	180	214.66 million	206.55 million	Optionable
WPC W.P. Carey	190	218.98 million	216.94 million	Optionable
ZG Zillow Group	6,856	241.45 million	200.07 million	Optionable

HHH, TSHA, ZG, and WPC Headlines

Recent News About These Companies

Wells Fargo & Company Issues Positive Forecast for Zillow Group (NASDAQ:ZG) Stock Price

July 11 at 2:29 AM | americanbankingnews.com

US housing deficit grew to 4.7 million despite construction surge

July 9, 2025 | goskagit.comG

Wells Fargo & Company Boosts Zillow Group (NASDAQ:ZG) Price Target to $75.00

July 8, 2025 | marketbeat.com

Zillow Group, Inc. (NASDAQ:ZG) Shares Sold by Vontobel Holding Ltd.

July 6, 2025 | marketbeat.com

Investing in Zillow Group (NASDAQ:ZG) three years ago would have delivered you a 103% gain

July 1, 2025 | finance.yahoo.com

MFG Wealth Management Inc. Sells 13,305 Shares of Zillow Group, Inc. (NASDAQ:ZG)

June 26, 2025 | marketbeat.com

ZG Zillow Group, Inc. - Seeking Alpha

June 25, 2025 | seekingalpha.com

Zillow Group, Inc. (NASDAQ:ZG) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

June 25, 2025 | marketbeat.com

Zillow faces antitrust lawsuit from Compass over listing restrictions

June 24, 2025 | usatoday.com

Real estate company Compass sues Zillow over consumers 'right to choose'

June 24, 2025 | foxbusiness.com

Compass is Suing Zillow Over New Listing Rules. Why Buyers and Sellers Should Pay Attention.

June 23, 2025 | barrons.com

Compass sues Zillow over privately marketed listings bans, escalating a long-running fight

June 23, 2025 | aol.comA

Compass sues Zillow, escalating private listings fight

June 23, 2025 | geekwire.comG

Assenagon Asset Management S.A. Reduces Stock Holdings in Zillow Group, Inc. (NASDAQ:ZG)

June 18, 2025 | marketbeat.com

AGM vs. ZG: Which Stock Is the Better Value Option?

June 17, 2025 | zacks.com

SG Americas Securities LLC Buys 15,042 Shares of Zillow Group, Inc. (NASDAQ:ZG)

June 17, 2025 | marketbeat.com

3,702 Shares in Zillow Group, Inc. (NASDAQ:ZG) Acquired by Optas LLC

June 16, 2025 | marketbeat.com

3,756 Shares in Zillow Group, Inc. (NASDAQ:ZG) Acquired by Wealth Enhancement Advisory Services LLC

June 16, 2025 | marketbeat.com

Rhumbline Advisers Has $3.41 Million Position in Zillow Group, Inc. (NASDAQ:ZG)

June 15, 2025 | marketbeat.com

Zillow Group, Inc. (NASDAQ:ZG) Director Thielke Claire Cormier Sells 241 Shares

June 14, 2025 | insidertrades.com

Insider Selling: Zillow Group, Inc. (NASDAQ:ZG) Director Sells 965 Shares of Stock

June 10, 2025 | insidertrades.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Why BigBear.ai Could Rally 100% and Catch Palantir Soon
By Gabriel Osorio-Mazilli | June 30, 2025
View Why BigBear.ai Could Rally 100% and Catch Palantir Soon
3 Defense Leaders Set to Gain From Rising Military Spend
By Chris Markoch | July 5, 2025
View 3 Defense Leaders Set to Gain From Rising Military Spend
IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
By Dan Schmidt | June 20, 2025
View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
By Gabriel Osorio-Mazilli | June 23, 2025
View BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
Cantor Boosts Rocket Lab Target to Street-High $35
By Ryan Hasson | June 19, 2025
View Cantor Boosts Rocket Lab Target to Street-High $35

HHH, TSHA, ZG, and WPC Company Descriptions

Howard Hughes NYSE:HHH

$70.52 -0.03 (-0.04%)

Closing price 03:59 PM Eastern

Extended Trading

$71.26 +0.75 (+1.06%)

As of 07:46 PM Eastern

Howard Hughes Holdings Inc., together with its subsidiaries, operates as a real estate development company in the United States. It operates in four segments: Operating Assets; Master Planned Communities (MPCs); Seaport; and Strategic Developments. The Operating Assets segment consists of developed or acquired retail, office, and multi-family properties along with other retail investments. Its MPCs segment develops, sells, and leases residential and commercial land designated for long-term community development projects in and around Las Vegas, Nevada; Houston, Texas; and Phoenix, Arizona. The Seaport segment is involved in the landlord operations, managed businesses, and events and sponsorships services of its restaurant, retail, and entertain properties in Pier 17, New York City; Historic Area/Uplands; and Tin Building, as well as in 250 Water Street and in the Jean-Georges restaurants. The Strategic Development segment develops and redevelops residential condominiums and commercial properties. It serves homebuilders. Howard Hughes Holdings Inc. was founded in 2010 and is headquartered in The Woodlands, Texas.

Taysha Gene Therapies NASDAQ:TSHA

$2.64 0.00 (0.00%)

Closing price 04:00 PM Eastern

Extended Trading

$2.64 +0.00 (+0.19%)

As of 05:37 PM Eastern

Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 for the treatment of for SLC13A5 deficiency; TSHA-113 for the treatment of tauopathies; TSHA-106 for the treatment of angelman syndrome; TSHA-114 for the treatment of fragile X syndrome; and TSHA-101 for the treatment of GM2 gangliosidosis. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center. Taysha Gene Therapies, Inc. was incorporated in 2019 and is headquartered in Dallas, Texas.

W.P. Carey NYSE:WPC

$63.50 +0.66 (+1.05%)

Closing price 03:59 PM Eastern

Extended Trading

$62.94 -0.56 (-0.88%)

As of 07:50 PM Eastern

W. P. Carey ranks among the largest net lease REITs with a well-diversified portfolio of high-quality, operationally critical commercial real estate, which includes 1,424 net lease properties covering approximately 173 million square feet and a portfolio of 89 self-storage operating properties as of December 31, 2023. With offices in New York, London, Amsterdam and Dallas, the company remains focused on investing primarily in single-tenant, industrial, warehouse and retail properties located in the U.S. and Northern and Western Europe, under long-term net leases with built-in rent escalations.

Zillow Group NASDAQ:ZG

$76.18 +0.87 (+1.16%)

Closing price 04:00 PM Eastern

Extended Trading

$75.74 -0.45 (-0.58%)

As of 07:03 PM Eastern

Zillow Group, Inc. operates real estate brands in mobile applications and Websites in the United States. The company offers premier agent and rentals marketplaces, new construction marketplaces, advertising, display advertising, and business technology solutions, as well as dotloop and floor plans. It also provides mortgage originations and the sale of mortgages, and advertising to mortgage lenders and other mortgage professionals; and title and escrow services. In addition, the company's brand portfolio includes Zillow Premier Agent, Zillow Home Loans, Zillow Rentals, Trulia, StreetEasy, HotPads, and Out East; and a suite of marketing software and technology solutions for the real estate industry, including ShowingTime+, Spruce, and Follow Up Boss. Zillow Group, Inc. was incorporated in 2004 and is headquartered in Seattle, Washington.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time